Gao Hanlin Sells 1,645 Shares of Fulgent Genetics Common Stock

On April 26, 2026, Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, Inc., disposed of 1,645 shares of common stock. The shares were withheld to cover tax obligations arising from the vesting of restricted stock units, which were assumed in a merger transaction on November 7, 2022. The transaction was reported on Form 4. Following this transaction, Mr. Hanlin owns 993,007 shares of common stock. The withholding was done at a price of $16.31 per share.